Among PCOS patients, the expression of the aromatase gene in granulosa cells is reduced by mitogen-activated protein kinase (MAPK) and PI3K, which is an expression of leptin resistance. The gene discussed is CYP19A1; the disease is polycystic ovary syndrome.